Kevin O Turner1,2, Robert M Genta1,2, Amnon Sonnenberg3,4. 1. Miraca Life Sciences, Irving, Texas, USA. 2. Baylor College of Medicine, Houston, Texas, USA. 3. Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon, USA. 4. Gastroenterology Section, Portland VA Medical Center, Portland, Oregon, USA.
Abstract
OBJECTIVES: Although large polyps are known to harbor more advanced neoplasia than small polyps, the extent of the relationship between size and type is not fully known. The study aim was to establish benchmarks for the prevalence of different histologic polyp types among varying size categories. METHODS: The Miraca Life Sciences Database is an electronic repository of histopathologic patient records from private practices throughout the United States. We extracted the records of 483,998 unique patients who underwent colonoscopy with polypectomy between January 2008 and December 2014. A total of 550,811 polyps were stratified by their endoscopic size measurement. Polyps of each size were further stratified as hyperplastic polyp (HP), tubular adenoma (TA), tubulovillous adenoma (TVA), sessile serrated adenoma/polyp, and adenocarcinoma. RESULTS: Of all 550,811 polyps, 447,343 (81%) were 1-9 mm in size, and 103,517 (19%) were 10 mm or larger. A fraction of 18,591/550,811 polyps (3.4%) harbored histologic features of advanced adenoma, such as TVA, high-grade dysplasia, or cancer. Of these, 4,725/18,591 (25%) occurred in polyps 1-9 mm and 13,868/18,591 (75%) occurred in polyps 10 mm or larger. The fractions of advanced adenoma were 0.6% (0.5-0.6%) in 1-5 mm polyps and 2.1% (2.0-2.2%) in 6-9 mm polyps, as compared to 13.4% (13.2-13.6%) in polyps 10 mm or larger. The frequency of HP significantly decreased with increasing polyp size, whereas the frequency of TA remained largely unaffected by polyp size. CONCLUSIONS: While advanced histopathology was found more frequently in colorectal polyps of larger than smaller size, one quarter of all advanced histopathology existed in polyps of <10 mm.
OBJECTIVES: Although large polyps are known to harbor more advanced neoplasia than small polyps, the extent of the relationship between size and type is not fully known. The study aim was to establish benchmarks for the prevalence of different histologic polyp types among varying size categories. METHODS: The Miraca Life Sciences Database is an electronic repository of histopathologic patient records from private practices throughout the United States. We extracted the records of 483,998 unique patients who underwent colonoscopy with polypectomy between January 2008 and December 2014. A total of 550,811 polyps were stratified by their endoscopic size measurement. Polyps of each size were further stratified as hyperplastic polyp (HP), tubular adenoma (TA), tubulovillous adenoma (TVA), sessile serrated adenoma/polyp, and adenocarcinoma. RESULTS: Of all 550,811 polyps, 447,343 (81%) were 1-9 mm in size, and 103,517 (19%) were 10 mm or larger. A fraction of 18,591/550,811 polyps (3.4%) harbored histologic features of advanced adenoma, such as TVA, high-grade dysplasia, or cancer. Of these, 4,725/18,591 (25%) occurred in polyps 1-9 mm and 13,868/18,591 (75%) occurred in polyps 10 mm or larger. The fractions of advanced adenoma were 0.6% (0.5-0.6%) in 1-5 mm polyps and 2.1% (2.0-2.2%) in 6-9 mm polyps, as compared to 13.4% (13.2-13.6%) in polyps 10 mm or larger. The frequency of HP significantly decreased with increasing polyp size, whereas the frequency of TA remained largely unaffected by polyp size. CONCLUSIONS: While advanced histopathology was found more frequently in colorectal polyps of larger than smaller size, one quarter of all advanced histopathology existed in polyps of <10 mm.
Authors: Neil Gupta; Ajay Bansal; Deepthi Rao; Dayna S Early; Sreenivasa Jonnalagadda; Sachin B Wani; Steven A Edmundowicz; Prateek Sharma; Amit Rastogi Journal: Gastrointest Endosc Date: 2012-03-09 Impact factor: 9.427
Authors: David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin Journal: Gastroenterology Date: 2012-07-03 Impact factor: 22.682
Authors: C Hassan; P J Pickhardt; D H Kim; E Di Giulio; A Zullo; A Laghi; A Repici; F Iafrate; J Osborn; B Annibale Journal: Aliment Pharmacol Ther Date: 2009-10-08 Impact factor: 8.171
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Silvana Marques e Silva; Viviane Fernandes Rosa; Antônio Carlos Nóbrega dos Santos; Romulo Medeiros de Almeida; Paulo Gonçalves de Oliveira; João Batista de Sousa Journal: Arq Bras Cir Dig Date: 2014 Apr-Jun
Authors: Frank Hoentjen; Michiel E de Jong; Iris D Nagtegaal; Shoko Vos; Rachel S van der Post; Yasmijn van Herwaarden; Lauranne A A P Derikx Journal: Dig Dis Sci Date: 2022-04-05 Impact factor: 3.199
Authors: Reinier G S Meester; Iris Lansdorp-Vogelaar; Sidney J Winawer; Ann G Zauber; Amy B Knudsen; Uri Ladabaum Journal: Ann Intern Med Date: 2019-09-24 Impact factor: 25.391
Authors: Andrea Gini; Reinier G S Meester; Homa Keshavarz; Kevin C Oeffinger; Sameera Ahmed; David C Hodgson; Iris Lansdorp-Vogelaar Journal: J Natl Cancer Inst Date: 2019-11-01 Impact factor: 13.506
Authors: Maja Čebohin; Senka Samardžić; Ksenija Marjanović; Martina Tot Vesić; Kristina Kralik; Andreja Bartulić; Dijana Hnatešen Journal: Int J Environ Res Public Health Date: 2020-11-10 Impact factor: 3.390
Authors: Dan Yoon; Hyoun-Joong Kong; Byeong Soo Kim; Woo Sang Cho; Jung Chan Lee; Minwoo Cho; Min Hyuk Lim; Sun Young Yang; Seon Hee Lim; Jooyoung Lee; Ji Hyun Song; Goh Eun Chung; Ji Min Choi; Hae Yeon Kang; Jung Ho Bae; Sungwan Kim Journal: Sci Rep Date: 2022-01-07 Impact factor: 4.379